Shenyang Xinsong Medical Technology Co., Ltd. was founded in November 2000. It is jointly invested and established by three legal entities including Shenyang Institute of Automation, Chinese Academy of Sciences, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Shenyang Branch of Chinese Academy of Sciences, and some natural persons and core employees of the company. China has 50.16% of the high-tech enterprises.

On June 10, 2014, the company was listed on the National Small and Medium Enterprises Stock Transfer System, with the stock code: 830803, and the securities abbreviation: "Xinsong Medical".

Xinsong Medical is mainly engaged in the research, development, production and manufacturing of respiratory rehabilitation products such as medical oxygen machines and non-invasive ventilators. It is an advanced respiratory rehabilitation solution provider in the industry. The company's products have reached advanced domestic and international levels.

Based on the principle of "relying on users, constantly innovating, and dedicating human health", Xinsong Medical has established a complete quality management system under the guidance of "quality, attitude, service, and innovation", and has successively passed the ISO13485 medical device quality. Management system certification and JGMP Japanese medical device quality system certification, the products have passed China NMPA certification, EU CE certification, US FDA certification, and MDSAP multi-country certification.

The company has formed a domestic sales service network. After years of cultivation, the international market has covered 100 countries and regions including Europe, North America, South America, Asia, Africa and Oceania.